Enanta Pharmaceuticals (NASDAQ:ENTA – Get Free Report) and Verrica Pharmaceuticals (NASDAQ:VRCA – Get Free Report) are both small-cap healthcare companies, but which is the better business? Get Enanta Pharmaceuticals alerts:Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Enanta Pharmaceuticals $65.32 million 5.89 -$81.89 million ($2.59) -5.10 Verrica Pharmaceuticals $37.16 million 2.55 -$17.89 million ($1.03) -5.35Analyst RecommendationsVerrica Pharmaceuticals has lower revenue, but higher earnings than Enanta Pharmaceuticals. Given Verrica Pharmaceuticals’ higher possible upside, analysts clearly believe Verrica Pharmaceuticals is more favorable than Enanta Pharmaceuticals. ProfitabilityThis table compares Enanta Pharmaceuticals and Verrica Pharmaceuticals’ net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Enanta Pharmaceuticals -89.56% -64.04% -20.22% Verrica Pharmaceuticals -47.97% -1,077.78% -40.76%Insider and Institutional Ownership95.0% of Enanta Pharmaceuticals shares are owned by institutional investors.